These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25787152)

  • 1. High-content screening technology for studying drug-induced hepatotoxicity in cell models.
    Tolosa L; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2015 Jul; 89(7):1007-22. PubMed ID: 25787152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates.
    Andersson TB
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):234-238. PubMed ID: 28470941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs.
    Tolosa L; Pinto S; Donato MT; Lahoz A; Castell JV; O'Connor JE; Gómez-Lechón MJ
    Toxicol Sci; 2012 May; 127(1):187-98. PubMed ID: 22331495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis.
    Trask OJ; Moore A; LeCluyse EL
    Assay Drug Dev Technol; 2014; 12(1):16-27. PubMed ID: 24444127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
    Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
    Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies.
    Donato MT; Gómez-Lechón MJ; Tolosa L
    Expert Opin Drug Discov; 2017 Feb; 12(2):201-211. PubMed ID: 27936962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high content screening assay to predict human drug-induced liver injury during drug discovery.
    Persson M; Løye AF; Mow T; Hornberg JJ
    J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective.
    Calitz C; Hamman JH; Fey SJ; Wrzesinski K; Gouws C
    Toxicol Mech Methods; 2018 Jun; 28(5):369-385. PubMed ID: 29297242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-content analysis/screening for predictive toxicology: application to hepatotoxicity and genotoxicity.
    Persson M; Løye AF; Jacquet M; Mow NS; Thougaard AV; Mow T; Hornberg JJ
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):18-23. PubMed ID: 24461077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of hepatotoxicity.
    Meyer SA
    Curr Protoc Toxicol; 2001 Aug; Chapter 14():Unit 14.1. PubMed ID: 23045037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity.
    Van den Hof WF; Van Summeren A; Lommen A; Coonen ML; Brauers K; van Herwijnen M; Wodzig WK; Kleinjans JC
    Toxicology; 2014 Oct; 324():18-26. PubMed ID: 25047351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Hepatotoxicity in iPSC-Derived Hepatocytes by Multiplexed High Content Assays.
    Sirenko O; Cromwell EF
    Methods Mol Biol; 2018; 1683():339-354. PubMed ID: 29082501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity.
    Peyre L; de Sousa G; Barcellini-Couget S; Luzy AP; Zucchini-Pascal N; Rahmani R
    Toxicol In Vitro; 2015 Oct; 29(7):1916-31. PubMed ID: 26239606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivities of gel entrapped hepatocytes in hollow fibers to hepatotoxic drug.
    Meng Q; Zhang G; Shen C; Qiu H
    Toxicol Lett; 2006 Sep; 166(1):19-26. PubMed ID: 16814964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity.
    Meng Q
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):733-46. PubMed ID: 20380484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes.
    Tolosa L; Jiménez N; Pelechá M; Castell JV; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2019 Feb; 93(2):519-532. PubMed ID: 30426164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.